Loading
NT
Nightstar Therapeutics plc Stock: price and insider trades · United States
Nightstar Therapeutics plc: what insiders have been doing
Nightstar Therapeutics plc is a listed company. Filings by its managers are published through SEC (Form 4). Nightstar Therapeutics plc has had no insider filing for more than a year; the last one goes back to 11 June 2019.
Looking back to 2019, when coverage begins, insiders filed no purchases and 10 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
21
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€610,650
10 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
Net income-32.9M
Last declaration on 11 June 2019
Declarations21 total
●
Same trade as the filing by Christopher J. Hollowood, counted once
337M USD13SEC
13,203,922 shares@ US$25.50100.0% of flowOrdinary SharesSEC:0000899243-19-016389:0
617,090 shares@ US$25.5097.8% of flowOrdinary SharesSEC:0001209191-19-035557:0
6,662,532 shares@ US$25.50100.0% of flowOrdinary SharesSEC:0001209191-19-035594:0
37,237 shares@ US$25.50100.0% of flowOrdinary SharesSEC:0001209191-19-035568:0
29,124 shares@ US$25.50100.0% of flowOrdinary SharesSEC:0001209191-19-035563:0
103,182 shares@ US$25.5093.6% of flowOrdinary SharesSEC:0001209191-19-035576:0
80,479 shares@ US$25.5093.5% of flowOrdinary SharesSEC:0001209191-19-035572:0
13,203,922 shares@ US$25.50100.0% of flowOrdinary SharesSEC:0001209191-19-035560:0
74,568 shares@ US$25.50100.0% of flowOrdinary SharesSEC:0001209191-19-035587:0
126,886 shares@ US$25.5099.5% of flowOrdinary SharesSEC:0001209191-19-035582:0
●
Same trade as the filing by New Enterprise Associates 15, L.P., counted once
170M USD19SEC
6,662,532 shares@ US$25.50100.0% of flowOrdinary SharesSEC:0001209191-19-035598:0
391 shares@ US$25.310.3% of flowOrdinary SharesSEC:0001209191-19-023563:0
9,305 shares@ US$25.311.5% of flowOrdinary SharesSEC:0001209191-19-023559:0
410 shares@ US$25.310.4% of flowOrdinary SharesSEC:0001209191-19-023562:0
2,446 shares@ US$25.312.8% of flowOrdinary SharesSEC:0001209191-19-023560:0
406 shares@ US$12.980.2% of flowOrdinary SharesSEC:0001209191-19-003182:0
2,546 shares@ US$12.981.5% of flowOrdinary SharesSEC:0001209191-19-003181:0
425 shares@ US$19.980.3% of flowOrdinary SharesSEC:0001209191-19-003180:0
8,733 shares@ US$12.980.7% of flowOrdinary SharesSEC:0001209191-19-003179:0
4,070 shares@ US$12.002.2% of flowOrdinary SharesSEC:0001209191-19-002676:0
14,764 shares@ US$11.155.8% of flowOrdinary SharesSEC:0001209191-19-001963:0
21 of 21 declarations
About Nightstar Therapeutics plc
Nightstar Therapeutics plc is a biopharmaceutical company focused on developing gene therapies for rare eye diseases. It is listed on NASDAQ under the ticker NIGHT.
